RU2635564C2 - Композиция для лечения гипертензии и/или фиброза - Google Patents

Композиция для лечения гипертензии и/или фиброза Download PDF

Info

Publication number
RU2635564C2
RU2635564C2 RU2016112257A RU2016112257A RU2635564C2 RU 2635564 C2 RU2635564 C2 RU 2635564C2 RU 2016112257 A RU2016112257 A RU 2016112257A RU 2016112257 A RU2016112257 A RU 2016112257A RU 2635564 C2 RU2635564 C2 RU 2635564C2
Authority
RU
Russia
Prior art keywords
fibrosis
compound
present
pharmaceutically acceptable
subject
Prior art date
Application number
RU2016112257A
Other languages
English (en)
Russian (ru)
Other versions
RU2016112257A (ru
Inventor
Карен Аннетт ДАГГЕН
Original Assignee
Вектус Байосистемс Лимитед
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2013903573A external-priority patent/AU2013903573A0/en
Application filed by Вектус Байосистемс Лимитед filed Critical Вектус Байосистемс Лимитед
Publication of RU2016112257A publication Critical patent/RU2016112257A/ru
Application granted granted Critical
Publication of RU2635564C2 publication Critical patent/RU2635564C2/ru

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/32—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton containing six-membered aromatic rings
    • C07C235/34—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton containing six-membered aromatic rings having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07—Optical isomers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/09—Geometrical isomers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
RU2016112257A 2013-09-17 2014-09-17 Композиция для лечения гипертензии и/или фиброза RU2635564C2 (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AU2013903573 2013-09-17
AU2013903573A AU2013903573A0 (en) 2013-09-17 Compositions for the treatment of hypertension and/or fibrosis
PCT/AU2014/000923 WO2015039173A1 (en) 2013-09-17 2014-09-17 Compositions for the treatment of hypertension and/or fibrosis

Publications (2)

Publication Number Publication Date
RU2016112257A RU2016112257A (ru) 2017-10-20
RU2635564C2 true RU2635564C2 (ru) 2017-11-14

Family

ID=52687998

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2016112257A RU2635564C2 (ru) 2013-09-17 2014-09-17 Композиция для лечения гипертензии и/или фиброза

Country Status (22)

Country Link
US (1) US9458093B2 (zh)
EP (1) EP3046901B1 (zh)
JP (1) JP6122548B2 (zh)
KR (1) KR101736416B1 (zh)
CN (1) CN105683152B (zh)
AP (1) AP2016009079A0 (zh)
AU (1) AU2014324078B2 (zh)
BR (1) BR112016005601B1 (zh)
CA (1) CA2924356C (zh)
DK (1) DK3046901T3 (zh)
ES (1) ES2655455T3 (zh)
IL (1) IL244621A (zh)
MX (1) MX368865B (zh)
MY (1) MY172557A (zh)
NO (1) NO3046901T3 (zh)
NZ (1) NZ717927A (zh)
PH (1) PH12016500497A1 (zh)
PL (1) PL3046901T3 (zh)
RU (1) RU2635564C2 (zh)
SG (1) SG11201601642WA (zh)
UA (1) UA118111C2 (zh)
WO (1) WO2015039173A1 (zh)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2712140C2 (ru) * 2015-03-18 2020-01-24 Вектус Байосистемс Лимитед Композиции для лечения фиброза и связанных с фиброзом состояний

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9956166B2 (en) 2013-09-18 2018-05-01 Sorrento Therapeutics, Inc. Methods for administration and methods for treating cardiovascular diseases with resiniferatoxin
AU2016232977B2 (en) 2015-03-18 2019-05-16 Vectus Biosystems Limited Compositions for the treatment of kidney and/or liver disease
BR112018005619B1 (pt) * 2015-09-22 2022-11-29 Vectus Biosystems Limited Método para produzir um composto, composto e uso de um composto
IL262328B2 (en) * 2016-04-13 2023-04-01 Univ Nebraska Methods for administration and methods for treating cardiovascular diseases with resiniparatoxin
MY192402A (en) * 2016-07-28 2022-08-19 Vectus Biosystems Ltd Compositions for the treatment of pulmonary fibrosis

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2090552C1 (ru) * 1992-06-30 1997-09-20 Рон-Пуленк Агрошими Производные фенилбензамидов, способы их получения, фунгицидная композиция для защиты растений и способ борьбы с фунгицидными заболеваниями
WO2005120545A1 (en) * 2004-06-11 2005-12-22 Vectus Biosystems Limited Compositions and methods for treatment of cardiovascular disease
US20110082109A1 (en) * 2009-10-02 2011-04-07 Ajinomoto Co., Inc. Novel acyl guanidine derivatives
WO2015039172A1 (en) * 2013-09-17 2015-03-26 Vectus Biosystems Pty Ltd Compositions for the treatment of hypertension and/or fibrosis

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ604248A (en) * 2005-12-09 2014-07-25 Vectus Biosystems Ltd Vip fragments and methods of use

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2090552C1 (ru) * 1992-06-30 1997-09-20 Рон-Пуленк Агрошими Производные фенилбензамидов, способы их получения, фунгицидная композиция для защиты растений и способ борьбы с фунгицидными заболеваниями
WO2005120545A1 (en) * 2004-06-11 2005-12-22 Vectus Biosystems Limited Compositions and methods for treatment of cardiovascular disease
US20110082109A1 (en) * 2009-10-02 2011-04-07 Ajinomoto Co., Inc. Novel acyl guanidine derivatives
WO2015039172A1 (en) * 2013-09-17 2015-03-26 Vectus Biosystems Pty Ltd Compositions for the treatment of hypertension and/or fibrosis

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
MARTIN PETERS et al. "A modular synthesis of teraryl-based α-Helix mimetics, Part 1: Synthesis of core fragments with two electronically differentiated leaving groups", CHEMISTRY-A EUROPEAN JOURNAL, 2013, vol.19, p.2442-2449. *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2712140C2 (ru) * 2015-03-18 2020-01-24 Вектус Байосистемс Лимитед Композиции для лечения фиброза и связанных с фиброзом состояний

Also Published As

Publication number Publication date
AP2016009079A0 (en) 2016-03-31
AU2014324078B2 (en) 2016-12-15
PH12016500497B1 (en) 2016-06-13
PL3046901T3 (pl) 2018-03-30
NO3046901T3 (zh) 2018-03-17
MX368865B (es) 2019-08-02
CA2924356C (en) 2018-04-03
RU2016112257A (ru) 2017-10-20
CA2924356A1 (en) 2015-03-26
IL244621A (en) 2017-04-30
CN105683152B (zh) 2017-03-22
CN105683152A (zh) 2016-06-15
UA118111C2 (uk) 2018-11-26
BR112016005601A8 (pt) 2020-02-18
SG11201601642WA (en) 2016-04-28
EP3046901A4 (en) 2017-04-12
IL244621A0 (en) 2016-04-21
MY172557A (en) 2019-12-02
DK3046901T3 (en) 2018-01-02
JP6122548B2 (ja) 2017-04-26
US9458093B2 (en) 2016-10-04
NZ717927A (en) 2018-12-21
EP3046901A1 (en) 2016-07-27
JP2016532632A (ja) 2016-10-20
MX2016003371A (es) 2016-10-21
AU2014324078A1 (en) 2016-04-07
PH12016500497A1 (en) 2016-06-13
US20160221933A1 (en) 2016-08-04
WO2015039173A1 (en) 2015-03-26
BR112016005601B1 (pt) 2021-02-02
ES2655455T3 (es) 2018-02-20
KR101736416B1 (ko) 2017-05-16
KR20160074471A (ko) 2016-06-28
EP3046901B1 (en) 2017-10-18

Similar Documents

Publication Publication Date Title
RU2635564C2 (ru) Композиция для лечения гипертензии и/или фиброза
JPWO2008139879A1 (ja) Ｇ蛋白質共役型レセプター抑制剤および医薬
CN109641852B (zh) 作为gpr40-和gpr120-激动剂的磺酰胺
US20100184860A1 (en) Novel Carboxylic Acid and Antidepressant Composition Containing the Same as Active Ingredient
TW201904968A (zh) 以三唑并吡啶治療rbp4相關疾病之方法
CA2924353A1 (en) Compositions for the treatment of hypertension and/or fibrosis
US10344001B2 (en) Azolylacryloyl derivatives as therapeutic agents for sickle cell disease
CN104473938A (zh) 一种治疗慢性心衰药物及其制备方法
US20150335624A1 (en) Compositions and methods for using huperzine and analogs thereof
EP3050567B1 (en) Compound for activating ampk and uses thereof
US20210346331A1 (en) Trpv4 activity inhibitor
JP2010168290A (ja) インターロイキン−２産生抑制剤
KR100903974B1 (ko) 2,4,5-삼중치환-1,3-티아졸 유도체 및 약제학적으로 허용가능한 그의 염, 그의 제조방법 및 그를 유효성분으로함유하는 ｓｐｃ 수용체 활성으로 유발되는 염증관련 질환치료제
RU2712624C2 (ru) Композиции для лечения заболевания почек и/или печени
KR102078433B1 (ko) 변비증의 예방 또는 치료약
CN110996932A (zh) 环苯扎林和阿米替林的类似物
TWI841532B (zh) 以稠合雙環吡唑治療代謝疾病之方法
JPH05503510A (ja) 光学的に純粋な（ｓ）―アテノロールを含む組成物と方法
CN105622528B (zh) 一种治疗肺动脉高压的化合物及其应用
CN105198810A (zh) 2-苄基-1-异喹啉酮类化合物及其合成方法和用途
KR101051077B1 (ko) 2-피페라지노-4,5-이중치환-1,3-티아졸 유도체, 그의 제조방법 및 그를 유효성분으로 함유하는 ｓｐｃ 수용체 활성으로 유발되는 염증관련질환 치료제
CN115770238A (zh) 大麻素类化合物cbe的制备方法及其医药用途
KR20100064953A (ko) 염증관련 질환치료제용 2,4-이중치환-5-아미노카르보닐-1,3-티아졸 유도체, 그의 제조방법 및 그를 유효성분으로 함유하는 ｓｐｃ 수용체 활성으로 유발되는 염증관련질환 치료제
JP2020527168A (ja) アザピロン系化合物の副交感神経の機能向上の使用
TW201904967A (zh) 以稠合雙環吡唑治療代謝疾病之方法